ACBD5
Acyl-CoA-binding domain-containing protein 5
Also known as: ACBD5_HUMAN, DKFZp434A2417, KIAA1996
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T8D3
- Gene
- ACBD5
- Ensembl
- ENSG00000107897
- Chromosome
- 10
- Canonical length
- 534 aa
- Protein class
- Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Peroxisomes
OverviewNCBI Gene
This gene encodes a member of the acyl-Coenzyme A binding protein family, known to function in the transport and distribution of long chain acyl-Coenzyme A in cells. This gene may play a role in the differentiation of megakaryocytes and formation of platelets. A related protein in yeast is involved in autophagy of peroxisomes. A mutation in this gene has been associated with autosomal dominant thrombocytopenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
534 residues, UniProt reviewed canonical sequence.
>Q5T8D3|ACBD5
1 MFQFHAGSWE SWCCCCLIPA DRPWDRGQHW QLEMADTRSV HETRFEAAVK VIQSLPKNGS
61 FQPTNEMMLK FYSFYKQATE GPCKLSRPGF WDPIGRYKWD AWSSLGDMTK EEAMIAYVEE
121 MKKIIETMPM TEKVEELLRV IGPFYEIVED KKSGRSSDIT SVRLEKISKC LEDLGNVLTS
181 TPNAKTVNGK AESSDSGAES EEEEAQEEVK GAEQSDNDKK MMKKSADHKN LEVIVTNGYD
241 KDGFVQDIQN DIHASSSLNG RSTEEVKPID ENLGQTGKSA VCIHQDINDD HVEDVTGIQH
301 LTSDSDSEVY CDSMEQFGQE ESLDSFTSNN GPFQYYLGGH SSQPMENSGF REDIQVPPGN
361 GNIGNMQVVA VEGKGEVKHG GEDGRNNSGA PHREKRGGET DEFSNVRRGR GHRMQHLSEG
421 TKGRQVGSGG DGERWGSDRG SRGSLNEQIA LVLMRLQEDM QNVLQRLQKL ETLTALQAKS
481 STSTLQTAPQ PTSQRPSWWP FEMSPGVLTF AIIWPFIAQW LVYLYYQRRR RKLNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACBD5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- liver: 69 nTPM
- spinal cord: 39 nTPM
- heart muscle: 38 nTPM
- duodenum: 38 nTPM
- small intestine: 37 nTPM
- kidney: 35 nTPM
Single-cell type
- retinal pigment epithelial cells: 188 nCPM
- epicardial cells: 175 nCPM
- cardiomyocytes: 119 nCPM
- hepatocytes: 90 nCPM
- enterocytes: 77 nCPM
- cone photoreceptor cells: 77 nCPM
Immune cell
- gdT-cell: 15 nTPM
- MAIT T-cell: 15 nTPM
- non-classical monocyte: 15 nTPM
- classical monocyte: 13 nTPM
- myeloid DC: 13 nTPM
- intermediate monocyte: 13 nTPM
Brain region
- medulla oblongata: 66 nTPM
- white matter: 66 nTPM
- spinal cord: 65 nTPM
- thalamus: 64 nTPM
- basal ganglia: 64 nTPM
- cerebellum: 63 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACBD5.
Disease | AllUniProt
Conditions ACBD5 is implicated in, by any mechanism.
- Retinal dystrophy with leukodystrophy (RDLKD) MIM:618863
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 446 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinal dystrophy with leukodystrophy
- Retinal disorder
- Familial cancer of breast
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.87
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACBD5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACBD5 as an antibody target. Whether an autoantibody or antibody against ACBD5 could matter depends on whether native ACBD5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACBD5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACBD5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...